Personal information

Activities

Collapse all

Funding (34)

Functional and mechanism study of D-glucuronyl C5-epimerase in liver fibrosis

2023 to 2026 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

Mechanism and targets discovery underlying the metabolism of polysaccharide by bacterial

2022 to 2027 | Grant
National Key Research and Development Program (Beijing, CN)
Source: Self-asserted source
Kan Ding

Zhongshan research team leading talents, Bioactive structure domain, targeting, functional mechanism and anti-tumor drug development of polysaccharides

2022 to 2027 | Award
Zhongshan research team leading talents (Zhongshan, CN)
Source: Self-asserted source
Kan Ding

Development of key technologies and original varieties of carbohydrate drug research

2020 to 2024 | Grant
Shanghai municipal major science and technology projects (Shanghai, CN)
Source: Self-asserted source
Kan Ding

Functional and mechanism of Glypican-6 in pancreatic cancer and the tumor fibrosis

2019 to 2022 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

Key technology and library construction of functional polysaccharide components from traditional Chinese medicine

2019 to 2020 | Grant
Ministry of Science and Technology of the People’s Republic of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

Study on the construction and key technology of functional polysaccharide sub-library of traditional Chinese medicine

2019 to 2020 | Grant
National Science and Technology Major Project of the Ministry of Science and Technology of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

Function of C-5-epimeras of heparin sulfate in the dendrites morphogenesis and the underlying mechanism regulated by miRNA

2017 to 2020 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

Outstanding Academic Leader in Shanghai

2016 to 2018 | Award
Shanghai Committee of Science and Technology (Shanghai, CN)
Source: Self-asserted source
Kan Ding

Discovery and validation of Anti-pancreatic cancer new drug target molecules, Personalized Medicines-Molecular Signature-based Drug Discovery and Development

2016 to 2017 | Grant
Strategic Priority Research Program of the Chinese Academy of Sciences (Beijing, CN)
Source: Self-asserted source
Kan Ding

New drug target discovery and identification from anti-pancreatic cancer therapy, Personalized Medicines-Molecular Signature-based Drug Discovery and Development

2016 to 2017 | Grant
Strategic Priority Research Program of the Chinese Academy of Sciences (Beijing, CN)
Source: Self-asserted source
Kan Ding

The study of structure, SAR (structure activity relationship) and absorption mechanism of Dendrobium nobile and their product development

2015 to 2017 | Grant
Shanghai Committee of Science and Technology (Shanghai, CN)
Source: Self-asserted source
Kan Ding

The study of structure, SAR (structure activity relationship) and absorption mechanism of Dendrobium nobileand their product development

2015 to 2017 | Grant
Shanghai Committee of Science and Technology (Shanghai, CN)
Source: Self-asserted source
Kan Ding

“Hundred Leading Talent in Suzhou Industry District”

2015 to 2017 | Award
“Hundred Leading Talent in Suzhou Industry District” (Suzhou, CN)
Source: Self-asserted source
Kan Ding

“Guizhou Hundred Leading Talent”

2014 to 2016 | Award
Guizhou Hundred Leading Talent (Guizhou, CN)
Source: Self-asserted source
Kan Ding

Structure and mechanism study of molecular target-based anti-tumor glycan

2013 to 2017 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

Key technique study on preparation and quality control of polysaccharide

2012 to 2015 | Grant
Ministry of Science and Technology of the People's Republic of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

The mechanism underlying function of miR-149 in glioma and the application in new drug development

2012 to 2015 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

National Science Foundation for Distinguished Young Scholars of China

2011 to 2015 | Award
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

The interaction between Glycan and glycan binding protein-based high throughput screening of bioactive polysaccharide from herbal medicine

2010 to 2012 | Grant
The Committee of Science and Technology of Guangdong Province, Zhonghua (Guangdong, CN)
Source: Self-asserted source
Kan Ding

Targeting molecule discovery for new drug development

2009 to 2011 | Grant
Ministry of Science and Technology of the People's Republic of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

The study on anti-cancer (heptocarcinoma) new drug candidate (polysaccharide WSS25), ainhibitor of Id1 of transcription factor

2009 to 2010 | Grant
Ministry of Science and Technology of the People's Republic of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

Function, regulation mechanism by micro RNA etc. and their application study on new drug development of the metabolic sulfatases aimed at heparan sulfate chain on proteoglycan

2008 to 2010 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

The molecular mechanism and structural modification of HK-156, a inhibitor with anti-inflammatory and immunosuppression effects by targeting NF-kappaB signaling,

2008 to 2010 | Grant
Shanghai Key Laboratory of New Drug Design (Shanghai, CN)
Source: Self-asserted source
Kan Ding

“Mounting climbing action project”

2007 to present | Grant
University of Shanghai for Science and Technology (Shanghai, CN)
Source: Self-asserted source
Kan Ding

“Yulan Magnolia” Talent grant

2007 to present | Award
Shanghai Committee of Science and Technology (Shanghai, CN)
Source: Self-asserted source
Kan Ding

Heparan sulfate proteoglycan mimics–based anti-angiogenesis leading compounds discovery study by targeting Id1, The New Discovery Research of the Shanghai Institute of Materia Medica

2007 to 2009 | Grant
Chinese Academy of Sciences (Beijing, CN)
Source: Self-asserted source
Kan Ding

Mechanism study underlying heparan sulfate degradation of glypican-1 and syndecan-1 and tumor growth, invasion, and metastasis

2007 to 2009 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

“Shanghai Pu-Jiang Talent”

2007 to 2008 | Award
Shanghai Committee of Science and Technology (Shanghai, CN)
Source: Self-asserted source
Kan Ding

The Scientific Research Foundation of the State Human Resource Ministry

2006 to present | Award
State Human Resource Ministry (Beijing, CN)
Source: Self-asserted source
Kan Ding

“100 Talents Project” of Chinese Academy of Sciences

2006 to 2010 | Award
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

The structure and conformation analysis and techniques of polysaccharide involved in tumor growth

2006 to 2009 | Grant
The National High Technology Research and Development Program (863) of China (Beijing, CN)
Source: Self-asserted source
Kan Ding

The technique service platform of glycan extract and purification, structure elucidation, quality control and the mechanism for glycan based drug development

2006 to 2009 | Grant
Shanghai Committee of Science and Technology (Shanghai, CN)
Source: Self-asserted source
Kan Ding

Scientific Evaluation of the Toxicity Essence of Traditional Chinese Medicine

2006 to 2008 | Grant
National Key Basic Research Program (Beijing, CN)
Source: Self-asserted source
Kan Ding
How many people are using ORCID?